JP2022538926A5 - - Google Patents

Info

Publication number
JP2022538926A5
JP2022538926A5 JP2022500544A JP2022500544A JP2022538926A5 JP 2022538926 A5 JP2022538926 A5 JP 2022538926A5 JP 2022500544 A JP2022500544 A JP 2022500544A JP 2022500544 A JP2022500544 A JP 2022500544A JP 2022538926 A5 JP2022538926 A5 JP 2022538926A5
Authority
JP
Japan
Prior art keywords
poly
seq
antibody
ran
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022500544A
Other languages
English (en)
Japanese (ja)
Other versions
JP7579589B2 (ja
JP2022538926A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/040725 external-priority patent/WO2021007110A1/en
Publication of JP2022538926A publication Critical patent/JP2022538926A/ja
Publication of JP2022538926A5 publication Critical patent/JP2022538926A5/ja
Priority to JP2024185014A priority Critical patent/JP2025026843A/ja
Application granted granted Critical
Publication of JP7579589B2 publication Critical patent/JP7579589B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022500544A 2019-07-05 2020-07-02 Ranタンパク質関連神経学的疾患を処置するための方法 Active JP7579589B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024185014A JP2025026843A (ja) 2019-07-05 2024-10-21 Ranタンパク質関連神経学的疾患を処置するための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962871031P 2019-07-05 2019-07-05
US62/871,031 2019-07-05
US202063025096P 2020-05-14 2020-05-14
US63/025,096 2020-05-14
PCT/US2020/040725 WO2021007110A1 (en) 2019-07-05 2020-07-02 Methods for treating ran protein-associated neurological diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024185014A Division JP2025026843A (ja) 2019-07-05 2024-10-21 Ranタンパク質関連神経学的疾患を処置するための方法

Publications (3)

Publication Number Publication Date
JP2022538926A JP2022538926A (ja) 2022-09-06
JP2022538926A5 true JP2022538926A5 (https=) 2023-07-10
JP7579589B2 JP7579589B2 (ja) 2024-11-08

Family

ID=74114201

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022500544A Active JP7579589B2 (ja) 2019-07-05 2020-07-02 Ranタンパク質関連神経学的疾患を処置するための方法
JP2024185014A Pending JP2025026843A (ja) 2019-07-05 2024-10-21 Ranタンパク質関連神経学的疾患を処置するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024185014A Pending JP2025026843A (ja) 2019-07-05 2024-10-21 Ranタンパク質関連神経学的疾患を処置するための方法

Country Status (6)

Country Link
US (1) US20220267776A1 (https=)
EP (1) EP3994159A4 (https=)
JP (2) JP7579589B2 (https=)
AU (1) AU2020310843A1 (https=)
CA (1) CA3145291A1 (https=)
WO (1) WO2021007110A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10509045B2 (en) 2015-05-29 2019-12-17 University Of Florida Research Foundation, Incorporated Methods for diagnosing Huntington's disease
US10940161B2 (en) 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
WO2018195110A1 (en) 2017-04-17 2018-10-25 University Of Florida Research Foundation, Incorporated Regolation of ran translation by pkr and eif2a-p pathways
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
EP3688020A4 (en) 2017-09-25 2021-07-14 University of Florida Research Foundation, Incorporated IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS
AU2018342105B2 (en) 2017-09-26 2023-11-16 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
WO2021055880A1 (en) 2019-09-20 2021-03-25 University Of Florida Researchfoundation, Incorporated Detection of antibodies against ran proteins from serum and tissue lysates
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
EP4427049A4 (en) * 2021-11-01 2025-08-20 Univ Florida POLY-GA PROTEINS IN ALZHEIMER'S DISEASE
EP4440560A1 (en) 2021-12-01 2024-10-09 University Of Florida Research Foundation, Incorporated Small molecule inhibitors of repeat associated non-aug (ran) translation and combination therapies
WO2024097756A1 (en) * 2022-11-01 2024-05-10 University Of Florida Research Foundation, Incorporated Interrupted ran proteins in disease
WO2024173816A1 (en) * 2023-02-17 2024-08-22 The University Of North Carolina At Chapel Hill Methods of detecting telomere-encoded dipeptide repeat proteins and therapeutic applications
CN116693621B (zh) * 2023-03-02 2023-11-14 东北农业大学 抑制革兰氏阴性菌的窄谱抗菌肽pc及其制备方法和应用
WO2025019730A1 (en) * 2023-07-20 2025-01-23 University Of Florida Research Foundation, Incorporated Engineered ga antibodies for therapy development
WO2025128551A1 (en) * 2023-12-11 2025-06-19 University Of Florida Research Foundation, Incorporated Aav-based anti-ga therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014114660A1 (en) * 2013-01-22 2014-07-31 Deutsches Zentrum Für Neurodegenerative Erkrankungen E.V. (Dzne) Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
WO2014159247A1 (en) * 2013-03-14 2014-10-02 University Of Florida Research Foundation, Inc. Di-amino acid repeat-containing proteins associated with als
CA2955086A1 (en) * 2014-08-08 2016-02-11 Alector Llc Anti-trem2 antibodies and methods of use thereof
JP6432023B2 (ja) * 2014-12-02 2018-12-05 国立大学法人 東京医科歯科大学 脊髄小脳失調症31型(sca31)治療剤
US10509045B2 (en) * 2015-05-29 2019-12-17 University Of Florida Research Foundation, Incorporated Methods for diagnosing Huntington's disease
US10940161B2 (en) * 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
EP3664816A4 (en) * 2017-08-08 2021-05-19 Wave Life Sciences Ltd. OLIGONUCLEOTIDE COMPOSITIONS AND RELATED PROCESSES
EP3688020A4 (en) * 2017-09-25 2021-07-14 University of Florida Research Foundation, Incorporated IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS
AU2018342105B2 (en) * 2017-09-26 2023-11-16 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders

Similar Documents

Publication Publication Date Title
JP2022538926A5 (https=)
CN112105640B (zh) 检测神经退行性变的测定
JP2025026843A5 (https=)
AU2015326911C1 (en) Human-derived anti-dipeptide repeats (DPRs) antibody
JP2014509853A5 (https=)
US20030175682A1 (en) Screening for papilloma viruses
CN108350050A (zh) 淀粉样蛋白β中的表位及其构象选择性抗体
JP2021181450A (ja) 細胞内抗原に対して向けられた単一ドメイン抗体
CN110914685A (zh) Rep蛋白作为蛋白质抗原用于诊断试验
JP2019531716A5 (https=)
JP2023531069A (ja) アミロイドβ1-42に結合する抗体を使用する軸索損傷の予防
AU2012264943B2 (en) Means and methods for diagnosing and treating multiple sclerosis
JP5821198B2 (ja) 抗il28b抗体及びこれを用いたil28bの測定方法
JP2023040241A5 (https=)
WO2019066617A9 (ko) 항 c-met 항체 및 이의 용도
CN118184778A (zh) 一种AD7c-NTP单克隆抗体及其应用
JP2005522228A5 (https=)
Kierny et al. Generating recombinant antibodies against putative biomarkers of retinal injury
US20180306810A1 (en) Antibodies recognizing phosphorylation at specific amino acid residues of transactive response dna-binding protein 43
JP2024542939A5 (https=)
JP2018077194A (ja) Ro52/TRIM21タンパク質に対する自己抗体が認識するエピトープおよびその利用
CN109890844B (zh) 抗ninj-1抗体及其用途
CN1191274C (zh) 识别对虾白斑杆状病毒单链抗体的制备方法
HK1244444A1 (zh) 检测人dpp-4的测定法
JP2020060580A (ja) 抗il4−il13二重特異性抗体